Gilead's $2,340 price for coronavirus drug remdesivir draws criticism ⇅
#coronavirus remdesivir #gilead remdesivir #remdesivir usa #fda approval of remdesivir #News & Politics
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
READ MORE: https://6abc.com/remdesivir-adverse-side-effects-ramdesvir-usa-fda-approval-of/6281198/
#remdesivir #gilead #ramdesvir #remdesivir adverse side effects #covid